Rocatinlimab combined with TCS/TCI significantly improves moderate to severe atopic dermatitis, with progressive skin clearance over 24 weeks. The ROCKET-SHUTTLE trial showed significant improvements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results